Getting you a comprehensive review of the product
Reading every ingredient in the formula…
Reading every ingredient in the formula…
Join The Clean Sheet™ community
Science-backed beauty tips, ingredient alerts, and early access. Straight to your WhatsApp.
Join for free →
This serum boasts an impressive peptide blend with transparent active percentages, but its bold anti-aging claims outpace the publicly available finished-product evidence, requiring consumers to manage expectations.
₹799 • Analysed 20 August 2026
This Hyphen Copper Peptide Cocktail Serum is positioned as a premium anti-aging solution in the Indian market, with a consistent price of Rs. 799 for 30ml. While the brand transparently discloses high percentages of key peptides, many of its ambitious claims regarding wrinkle reduction and time-bound results lack finished-product clinical evidence, which could raise scrutiny under ASCI guidelines. The formula, being fragrance-free and rich in humectants, is generally suitable for India's varied climate, though the presence of colorants might be a minor consideration for very sensitive Indian skin types prone to reactivity.
Independent and free. The Clean Sheet takes no money from brands to review, rank, or approve a product. This is a web evidence review, not a Clean Sheet certification. We checked the ingredient list, publicly available test reports, marketing claims, and formula logic using only public information available at the time of review.
Brand explicitly states percentages for Copper Peptide (2%), Matrixyl 3000 (3%), Argireline (1%), and a 4% blend of 6 peptides, totaling 10%. These peptides are present high in the INCI list.
Aspirational claim; no finished product evidence publicly visible to support this broad promise.
Peptides and extracts in the formula (e.g., Copper Tripeptide-1, Matrixyl 3000, Ginseng) are known at an ingredient level to promote collagen, but no finished product evidence is publicly visible.
This is a quantified/clinical claim. No finished product clinical study with methodology, sample size, and results is publicly visible to support this specific claim.
No finished product evidence is publicly visible to support this claim. Ingredient-level research suggests peptides can help, but product-specific proof is absent.
Broad claim. While ingredients are associated with anti-aging benefits, no finished product evidence is publicly visible to substantiate this claim for the product itself.
While the active (Copper Peptide) is present at a disclosed percentage, this is an ingredient-level claim. The 'visibly reduce deep wrinkles' part is a clinical claim requiring finished product evidence, which is not publicly visible.
Claim associated with Matrixyl 3000. Ingredient-level research supports this, and the percentage is disclosed. However, finished product evidence is not publicly visible.
What we could confirm from public sources and the verified ingredient list.
Ingredient Safety & Toxicity
Full ingredient list retrieved and verified against the label.
Screened against the ingredient database (12 of 21 ingredients matched); no cosmetics-prohibited ingredient found.
No ingredient with a recognised endocrine-activity concern found in the database.
No IARC-classified or formaldehyde-releasing ingredient found in the database screen.
No commonly-comedogenic ingredient found - a reasonable fit for acne-prone skin.
Irritation & Allergen Risk
No EU-declarable or database-flagged allergen found in the list.
No high-sensitisation preservative (MI/MCI/formaldehyde-releaser) from our screen was found.
Ingredient Transparency
The full INCI list is publicly available, not just hero ingredients.
Active percentages are disclosed for the hero ingredient(s).
Any proprietary 'complex' is broken down into its actual ingredients.
Ingredients are listed in the descending order required by India Cosmetics Rules 2020.
Standards & Compliance
Usage warnings and directions are clear on the label.
No retinoid or other pregnancy-cautioned active found in the screen.
Screened against a curated reference set that we are continuing to verify and expand, so “clear” means no flag from that set, not a guarantee. Not a substitute for a full toxicological or clinical assessment.
| Ingredient |
|---|
Aqua |
Glycerin |
Butylene Glycol |
Propanediol |
Copper Tripeptide-1 |
Palmitoyl Tripeptide-1 |
Palmitoyl Tetrapeptide-7 |
Acetyl Hexapeptide-8 |
Palmitoyl Tripeptide-38 |
Acetyl Tetrapeptide-2 |
Panax Ginseng Root Extract |
Linum Usitatissimum (Linseed) Seed Extract |
Sodium Hyaluronate |
Phenoxyethanol |
Ethylhexylglycerin |
Xanthan Gum |
Disodium EDTA |
Citric Acid |
Sodium Hydroxide |
CI 42090 |
CI 16035 |
INCI order as declared on packaging. Position reflects approximate concentration (high to low).
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
Flags are based on publicly available INCI only. Not a substitute for full regulatory compliance review.
“Reduces wrinkles”
Absolute claim without verifiable clinical proof, potentially non-compliant with ASCI Chapter 1.4 (Truthful and Honest) and 4.1 (Personal Care & Health).
“Helps smoothen fine lines and visibly reduce deep wrinkles”
Quantified claim ('visibly reduce') without verifiable clinical proof for the finished product, potentially non-compliant with ASCI Chapter 1.4 and 4.1.
“Reduces wrinkles for a more youthful, rejuvenated look”
Absolute claim ('reduces') without verifiable clinical proof for the finished product, potentially non-compliant with ASCI Chapter 1.4 and 4.1.
“Expect visibly brighter, more even-toned skin in 4-6 weeks.”
Quantified and time-bound claim without verifiable clinical proof, potentially non-compliant with ASCI Chapter 1.4 and 4.1.
Brand explicitly states percentages for Copper Peptide (2%), Matrixyl 3000 (3%), Argireline (1%), and a 4% blend of 6 peptides, totaling 10%. These peptides are present high in the INCI list.
Mentioned only
Aspirational claim; no finished product evidence publicly visible to support this broad promise.
Missing
Peptides and extracts in the formula (e.g., Copper Tripeptide-1, Matrixyl 3000, Ginseng) are known at an ingredient level to promote collagen, but no finished product evidence is publicly visible.
Mentioned only
This is a quantified/clinical claim. No finished product clinical study with methodology, sample size, and results is publicly visible to support this specific claim.
Missing
No finished product evidence is publicly visible to support this claim. Ingredient-level research suggests peptides can help, but product-specific proof is absent.
Missing
Broad claim. While ingredients are associated with anti-aging benefits, no finished product evidence is publicly visible to substantiate this claim for the product itself.
Missing
While the active (Copper Peptide) is present at a disclosed percentage, this is an ingredient-level claim. The 'visibly reduce deep wrinkles' part is a clinical claim requiring finished product evidence, which is not publicly visible.
Mentioned only
Claim associated with Matrixyl 3000. Ingredient-level research supports this, and the percentage is disclosed. However, finished product evidence is not publicly visible.
Mentioned only
Claim associated with Matrixyl 3000. Ingredient-level research supports this, and the percentage is disclosed. However, 'reduces wrinkles' is a clinical claim requiring finished product evidence, which is not publicly visible.
Mentioned only
Claim associated with Argireline (Acetyl Hexapeptide-8). Ingredient-level research supports this, and the percentage is disclosed. No finished product evidence is publicly visible.
Mentioned only
Public evidence the brand could provide to close verification gaps
This review evaluates brand claims against visible evidence and formula logic. It does not replace a full ingredient safety analysis or a clinical product test. Results vary by individual, and the consumer should always read the full ingredient list and follow usage guidance.
Are you the brand? If you have published test data or want to request a re-review, write to us at hello@thecleansheet.in.
No IARC-classified or formaldehyde-releasing ingredient found in the database screen.
No commonly-comedogenic ingredient found - a reasonable fit for acne-prone skin.
Irritation & Allergen Risk
No EU-declarable or database-flagged allergen found in the list.
No high-sensitisation preservative (MI/MCI/formaldehyde-releaser) from our screen was found.
Ingredient Transparency
The full INCI list is publicly available, not just hero ingredients.
Active percentages are disclosed for the hero ingredient(s).
Any proprietary 'complex' is broken down into its actual ingredients.
Ingredients are listed in the descending order required by India Cosmetics Rules 2020.
Standards & Compliance
Usage warnings and directions are clear on the label.
No retinoid or other pregnancy-cautioned active found in the screen.
Screened against a curated reference set that we are continuing to verify and expand, so “clear” means no flag from that set, not a guarantee. Not a substitute for a full toxicological or clinical assessment.
This is a quantified/clinical claim. No finished product clinical study with methodology, sample size, and results is publicly visible to support this specific claim.
No finished product evidence is publicly visible to support this claim. Ingredient-level research suggests peptides can help, but product-specific proof is absent.
Broad claim. While ingredients are associated with anti-aging benefits, no finished product evidence is publicly visible to substantiate this claim for the product itself.
While the active (Copper Peptide) is present at a disclosed percentage, this is an ingredient-level claim. The 'visibly reduce deep wrinkles' part is a clinical claim requiring finished product evidence, which is not publicly visible.
Claim associated with Matrixyl 3000. Ingredient-level research supports this, and the percentage is disclosed. However, finished product evidence is not publicly visible.
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
No prohibited or restricted ingredients identified
Flags are based on publicly available INCI only. Not a substitute for full regulatory compliance review.
Brand explicitly states percentages for Copper Peptide (2%), Matrixyl 3000 (3%), Argireline (1%), and a 4% blend of 6 peptides, totaling 10%. These peptides are present high in the INCI list.
Mentioned only
Aspirational claim; no finished product evidence publicly visible to support this broad promise.
Missing
Peptides and extracts in the formula (e.g., Copper Tripeptide-1, Matrixyl 3000, Ginseng) are known at an ingredient level to promote collagen, but no finished product evidence is publicly visible.
Mentioned only
This is a quantified/clinical claim. No finished product clinical study with methodology, sample size, and results is publicly visible to support this specific claim.
Missing
No finished product evidence is publicly visible to support this claim. Ingredient-level research suggests peptides can help, but product-specific proof is absent.
Missing
Broad claim. While ingredients are associated with anti-aging benefits, no finished product evidence is publicly visible to substantiate this claim for the product itself.
Missing
While the active (Copper Peptide) is present at a disclosed percentage, this is an ingredient-level claim. The 'visibly reduce deep wrinkles' part is a clinical claim requiring finished product evidence, which is not publicly visible.
Mentioned only
Claim associated with Matrixyl 3000. Ingredient-level research supports this, and the percentage is disclosed. However, finished product evidence is not publicly visible.
Mentioned only
Claim associated with Matrixyl 3000. Ingredient-level research supports this, and the percentage is disclosed. However, 'reduces wrinkles' is a clinical claim requiring finished product evidence, which is not publicly visible.
Mentioned only
Claim associated with Argireline (Acetyl Hexapeptide-8). Ingredient-level research supports this, and the percentage is disclosed. No finished product evidence is publicly visible.
Mentioned only
“Reduces wrinkles”
Absolute claim without verifiable clinical proof, potentially non-compliant with ASCI Chapter 1.4 (Truthful and Honest) and 4.1 (Personal Care & Health).
“Helps smoothen fine lines and visibly reduce deep wrinkles”
Quantified claim ('visibly reduce') without verifiable clinical proof for the finished product, potentially non-compliant with ASCI Chapter 1.4 and 4.1.
“Reduces wrinkles for a more youthful, rejuvenated look”
Absolute claim ('reduces') without verifiable clinical proof for the finished product, potentially non-compliant with ASCI Chapter 1.4 and 4.1.
“Expect visibly brighter, more even-toned skin in 4-6 weeks.”
Quantified and time-bound claim without verifiable clinical proof, potentially non-compliant with ASCI Chapter 1.4 and 4.1.
Public evidence the brand could provide to close verification gaps
